Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 2, 2011, Pages 398-402

  Błogowski, Wojciech ^a   Marlicz, Wojciech ^a   Smereczyński, Andrzej ^a   Ławniczak, Małgorzata ^a   Lewosiuk, Agnieszka ^a   Starzyńska, Teresa ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Azathioprine; Crohn's disease; factor V Leiden; nodular regenerative hyperplasia; TPMT

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 5 LEIDEN; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; PROPRANOLOL; THIOPURINE METHYLTRANSFERASE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CASE REPORT; CROHN DISEASE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HEPATOSPLENOMEGALY; HUMAN; HYPERCOAGULABILITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER HYPERPLASIA; LIVER TOXICITY; NODULAR REGENERATIVE LIVER HYPERPLASIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; REGENERATIVE ABILITY; THROMBOCYTOPENIA;

ADULT; AZATHIOPRINE; CROHN DISEASE; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; LIVER REGENERATION; TREATMENT OUTCOME;

EID: 79955871296     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.509727     Document Type: Article

References (32)

1. Reshamwala, P.A., Kleiner, D.E., Heller, T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006, 44, 7-14. (Pubitemid 44049133)
2. Nakanuma, Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J. Clin. Gastroenterol. 1990, 12, 460-465. (Pubitemid 20234382)
3. Colina, F., Alberti, N., Solis, J.A., Martinez-Tello, F.J. Difuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989, 9, 253-265. (Pubitemid 19249669)
4. Blogowski, W. Facial transplantation as an option in reconstructive surgery: no mountains too high? ANZ. J. Surg. 2009, 79, 892-897.
5. Elariny, H.A., Mizrahi, S.S., Hayes, D.H., Boudreaux, J.P., Hussey, J.L., Farr, G.H. Jr. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl. Int. 1994, 7, 309-313. (Pubitemid 24186762)
6. Wanless, I.R. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classifcation of benign hepatocellular nodules. Hepatology 1990, 11, 787-797. (Pubitemid 20191384)
7. Vernier-Massouille, G., Cosnes, J., Lemann, M., Marteau, P., Reinisch, W., Laharie, D., Cadiot, G., Bouhnik, Y., De Vos, M., Boureille, A., Duclos, B., Seksik, P., Mary, J.Y., Colombel, J.F. Nodular regenerative hyperplasia in patients with infammatory bowel disease treated with azathioprine. Gut 2007, 56, 1404-1409. (Pubitemid 47517834)
8. Poppe, D., Tiede, I., Fritz, G., Becker, C., Bartsch, B., Wirtz, S., Strand, D., Tanaka, S., Galle, P.R., Bustelo, X.R., Neurath, M.F. Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J. Immunol. 2006, 176, 640-651. (Pubitemid 43023313)
9. de Boer, N.K., Tuynman, H., Bloemena, E., Westerga, J., Van Der Peet, D.L., Mulder, C.J., Cuesta, M.A., Meuwissen, S.G., Van Nieuwkerk, C.M., Van Bodegraven, A.A. Histopathology of liver biopsies from a thiopurine-naïve infammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia. Scand. J. Gastroenterol. 2008, 43, 604-608. (Pubitemid 351536051)
10. Dubinsky, M.C., Vasiliauskas, E.A., Singh, H., Abreu, M.T., Papadakis, K.A., Tran, T., Martin, P., Vierling, J.M., Geller, S.A., Targan, S.R., Poordad, F.F. 6-thioguanine can cause serious liver injury in infammatory bowel disease patients. Gastroenterology 2003, 125, 298-303. (Pubitemid 36929408)
11. Seksik, P., Mary, JY., Beaugerie, L., Colombel, J.F., Vernier, G., Cosnes, J. Incidence of nodular regenerative hyperplasia in infammatory bowel disease patients treated with azathioprine. Infamm. Bowel. Dis. 2010 (In Press).
12. Hillaire, S., Bonte, E., Denninger, M.H., Casadevall, N., Cadranel, J.F., Lebrec, D., Valla, D., Degott, C. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002, 51, 275-280. (Pubitemid 34791461)
13. Perez, R.F., Zea, M.A.C., Orte, M.F.J. Anti-phospholipid antibodies may play a role in pathogenesis of nodular regenerative hyperplasia of the liver. Br. J. Rheumatol. 1990, 29(Suppl 2), 107.
14. Austin, A., Campbell, E., Lane, P., Elias, E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anti-cardiolipin antibody. Gut 2004, 53, 1032-1034. (Pubitemid 38824164)
15. Haboubi, N.Y, Ali, H.H., Whitwell, H.L., Ackrill, P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am. J. Gastroenterol. 1988, 83, 256-261.
16. Hubert, C., Sempoux, C., Horsmans, Y., Rahier, J., Humblet, Y., Machiels, J.P., Ceratti, A., Canon, J.L., Gigot, J.F. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver. Int. 2007, 27, 938-943. (Pubitemid 47261947)
17. Ziol, M., Poirel, H., Kountchou, G.N., Boyer, O., Mohand, D., Mouthon, L., Tepper, M., Guillet, J.G., Guettier, C., Raphael, M., Beaugrand, M. Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver. Hum. Pathol. 2004, 35, 1241-1251. (Pubitemid 39361648)
18. DeLeve, L.D., Wang, X., Kuhlenkamp, J.F., Kaplowitz, N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996, 23, 589-599. (Pubitemid 26087175)
19. De Boer, N.K., van Bodegraven, A.A., Jharap, B., de Graaf, P., Mulder, C.J. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007, 4, 686-694. (Pubitemid 350199222)
20. De Boer, N.K., Mulder, C.J., van Bodegraven, A.A. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity. Liver. Transpl. 2005, 11, 1300-1301. (Pubitemid 41511949)
21. Breen, D.P., Marinaki, A.M., Arenas, M., Hayes, P.C. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver. Transpl. 2005, 11, 826-833. (Pubitemid 40975585)
22. Al Hadithy, A.F., de Boer, N.K., Derijks, L.J., Escher, J.C., Mulder, C.J., Brouwers, J.R. Tiopurines in infammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Dig. Liver. Dis. 2005, 37, 282-297. (Pubitemid 41070528)
23. Winter, J., Walker, A., Shapiro, D., Gafney, D., Spooner, R.J., Mills, P.R. Cost-efectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of infammatory bowel disease. Aliment. Pharmacol. Ter. 2004, 20, 593-599. (Pubitemid 39279046)
24. Dachman, A.H., Ros, P.R., Goodman, Z.D., Olmsted, W.W., Ishak, K.G. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR. Am. J. Roentgenol. 1987, 148, 717-722. (Pubitemid 17047757)
25. Wang, H.M., Lo, G.H., Hsu, P.I., Lin, C.K., Chan, H.H., Chen, W.C., Lai, K.H., Wang, B.W., Lin, S.L. Nodular regenerative hyperplasia of the liver. J. Chin. Med. Assoc. 2008, 71, 523-527.
26. Wanless, I.R., Peterson, P., Das, A., Boitnott, J.K., Moore, G.W., Bernier, V. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 1990, 12, 1166-1174.
27. O'Brien, K., Hussain, N., Warady, B.A., Kleiner, D.E., Kleta, R., Bernardini, I., Heller, T., Gahl, W.A. Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin. Gastroenterol. Hepatol. 2006, 4, 387-394. (Pubitemid 43343897)
28. Nakanuma, Y., Hoso, M., Sasaki, M., Terada, T., Katayanagi, K., Nonomura, A., Kurumaya, H., Harada, A., Obata, H. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996, 28, 195-204. (Pubitemid 26091910)
29. Seiderer, J., Zech, C.J., Diebold, J., Schoenberg, S.O., Brand, S., Tillack, C., Göke, B., Ochsenkühn, T. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur. J. Gastroenterol. Hepatol. 2006, 18, 553-555. (Pubitemid 43832759)
30. De Boer, N.K., Zondervan, P.E., Gilissen, L.P., den Hartog, G., Westerveld, B.D., Derijks, L.J., Bloemena, E., Engels, L.G., van Bodegraven, A.A., Mulder, C.J. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in infammatory bowel disease patients. Dig. Liver. Dis. 2008, 40, 108-113.
31. De Boer, N.K., Reinisch, W., Teml, A., van Bodegraven, A.A., Schwab, M., Lukas, M., Ochsenkühn, T., Petritsch, W., Knofach, P., Almer, S., van der Merwe, S.W., Herrlinger, K.R., Seiderer, J., Vogelsang, H., Mulder, C.J. 6-Tioguanine treatment in infammatory bowel disease: a critical appraisal by a European 6-TG working party. Digestion 2006, 73, 25-31. (Pubitemid 43800658)
32. Van Asseldonk, D.P., de Boer, N.K., Peters, G.J., Veldkamp, A.I., Mulder, CJ., Van Bodegraven, A.A. On therapeutic drug monitoring of thiopurines in infammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance. Curr. Drug. Metab. 2009, 10, 981-997.